Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenomics: questions and concerns.

Current medical research and opinion - 1 Jul 2005

Mahlknecht Ulrich, Voelter-Mahlknecht Susanne

Abstract excerpt

The progressively aging population in the western world, rising socioeconomic expenditure and increasing costs for the treatment of adverse drug reactions, lead to increasing pressure on public spending. The public acceptance of pharmacogenomics is high, therefore, because it promises individuali...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Delivery of Health Care
Share to Drug Industry
Share to Drug Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Genetic Variation

Share to Genetics, Population

Share to Pharmacogenetics

Source

Identifiers

PMID: 16004671
DOI: 10.1185/030079905X50633

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-16004671-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenomics: questions and concerns.PMID 16004671Read ↗

The emerging era of pharmacogenomics: current successes, future potential, and challenges.Semantic proximity Read ↗

Pharmacogenomics and adverse drug reactions in diagnostic and clinical practice.Semantic proximity Read ↗

Advances in pharmacogenetics and pharmacogenomics.Semantic proximity Read ↗

Pharmacogenomics: historical perspective and current status.Semantic proximity Read ↗

Ethical, social and legal issues in pharmacogenomicsSemantic proximity Read ↗

The role of pharmacogenomics in adverse drug reactionsSemantic proximity Read ↗

Personalized Pharmacogenomics: Predicting Efficacy and Adverse Drug ReactionsSemantic proximity Read ↗

Pharmacogenomics: Challenges and OpportunitiesSemantic proximity Read ↗

Pharmacogenetics and pharmacogenomics: development, science, and translation.Semantic proximity Read ↗

[Drug therapy and pharmacogenomics--hopes and facts].Semantic proximity Read ↗

Pharmacogenomics.Semantic proximity Read ↗

Pharmacogenetics and pharmacogenomicsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.